Escozine™ was originally developed and commercialized by Medolife, Corp. in 2007. Until 2007, this natural medicine has only been available in Cuba, where it is known as Escozul.
MedolifeRx:Will be a Potential Big Pharma BO...as it will be Cheaper for Them to Acquire The Whole Pie. Research/Pre-clinicals Toxicity/Efficacy Everything are already Done with Production and Distribution in Place.
For Future Insti-Buyers, it will be like Purchasing @ $5/sh equivalent to Retail Investors...purchasing now @ $0.10/sh